MedPath

Evaluation of the effectiveness of progressive muscle relaxation on maternal and neonatal outcomes on primary parous women with preeclampsia

Not Applicable
Recruiting
Conditions
Preeclampsia.
Eclampsia in pregnancy, unspecified trimester
O15.00
Registration Number
IRCT20180110038302N6
Lead Sponsor
Alborz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
88
Inclusion Criteria

primary parous women with 26-34 weeks gestational age
singleton pregnancy
non-severe preeclampsia criterias
low risk results in the frist and second trimester fetal screenings
persiane race and at least having reading and writing literacy

Exclusion Criteria

physical and mental illnesses (such as cardio-respiratory disease, diabetes mellitus and gestational diabetes, seizure, depression, anxiety disorders ,etc)
history of infertility and/or repeated miscarriage
vaginal hemorrhage and/or leaking amniotic fluid and/or uterine contractions
recent severe stress and/or anxiety
intrauterine growth restriction
usage of alcohol and/or cigarettes and/or drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: before and after 6 weeks of intervention. Method of measurement: mercury sphygmo manometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath